News and Trends 28 Apr 2025 U.S. budget cuts: what is the impact on therapeutic research? …relying on government progress on human immunodeficiency virus (HIV), Alzheimer’s, diabetes, or other public health challenges, if not reversed by the courts.” Out of the nearly 800 projects that have… April 28, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 2 Aug 2023 The biggest private biotech investments in July 2023 …Chinese firm Sinotau raised $152 million in financing to develop radiopharmaceutical drugs for cardiovascular diseases, Alzheimer’s disease, and cancer. Other life sciences investments in July 2023 There weren’t too many… August 2, 2023 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 21 Nov 2024 Huntington’s disease: a therapeutic field on a bumpy ride …neurodegenerative diseases like Huntington’s and Alzheimer’s disease. “We are very pleased with these new data demonstrating a statistically significant, dose-dependent slowing of the progression of Huntington’s disease and lowering of… November 21, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 1 Aug 2024 CureVac: From a failed drug to a €1.45 billion deal …and BioNTech to come out as victors in the COVID mRNA vaccine race, and history is often written by the victors. However, like Biogen after it failed with its Alzheimer’s… August 1, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 19 Jul 2022 Bayer Consumer Health launches microbiome research call to find new academic partners …Bayer Crop Science, Johnson & Johnson, Murata Manufacturing, Johnson Matthey, Air Products, and GSK Consumer Healthcare, as well as medical research charities including Alzheimer’s Research UK and Kidney Research UK…. July 19, 2022 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jun 2023 Med-Life Discoveries to start rare pediatric disease trial …legitimate, pharmaceutical-grade plasmalogen therapeutics for patients with RCDP, as well as other neurodegenerative diseases such as Alzheimer’s,” said Shawn Ritchie, chief executive officer and chief scientific officer at Med-Life Discoveries…. June 9, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 6 Aug 2025 Fusion proteins attract funds and biopharma partnerships …of Alzheimer’s disease when they accumulate in the brain. The candidate ILM01, which is in the lead optimization stage, is born from the startup’s Gas6-mediated Anti-Inflammatory Adaptor (GAIA) platform. The… August 6, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 14 Nov 2018 Parkinson’s Disease Vaccine Shows Preclinical Promise …in the clinic. United Neuroscience has used the same platform to make a vaccine against Alzheimer’s disease, which is currently being tested in Phase II, with results expected at… November 14, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 23 Mar 2023 Hearing loss research: Five advancements in the past year …Institute at SDU. This followed a study in 2021 that found a correlation between traffic noise and dementia, particularly Alzheimer’s disease. These findings contribute to the growing evidence of sounds… March 23, 2023 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 28 Apr 2020 Anti-Aging Treatments at Forefront of Astellas’ €80M UK Acquisition …mitochondrial function in order to treat age-related diseases such as Alzheimer’s disease and cancer. It is also developing a treatment for a genetic syndrome called mitochondrial encephalopathy, lactic acidosis, and… April 28, 2020 - 3 minutesmins - By David Kirk Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jul 2023 NodThera first to show reduction in neuroinflammation with inflammasome inhibitor …justify our confidence in the potential of NT-0796 to treat diseases such as Parkinson’s disease and Alzheimer’s disease.” Paul Matthews, head of the Department of Brain Sciences in the Faculty… July 11, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 Apr 2025 13 anti-aging startups on a mission to extend lives …organs. The company also has four preclinical candidates in its pipeline for the treatment of muscle wasting, rheumatoid arthritis, heart failure, and Alzheimer’s disease. Back in 2019, the anti-aging company… April 8, 2025 - 19 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email